Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

被引:0
|
作者
Yoshida, N. [1 ]
Yabe, H. [2 ]
Kudo, K. [3 ]
Kobayashi, R. [4 ]
Yabe, M. [2 ]
Inoue, M. [5 ,6 ]
Miki, M. [7 ]
Sakamaki, H. [8 ]
Kawa, K. [9 ]
Suzuki, R. [10 ]
Kato, K. [1 ]
Watanabe, K. -I. [11 ]
Kojima, S. [12 ]
机构
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan
[4] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan
[5] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Japan
[6] Res Inst Maternal & Child Hlth, Izumi, Japan
[7] Hiroshima Univ, Dept Pediat, Grad Sch Biomed Sci, Hiroshima, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[9] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Japan
[10] Nagoya Univ, Dept HSCT Data Management & Biostat, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[11] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan
[12] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O151
引用
收藏
页码:S89 / S89
页数:1
相关论文
共 50 条
  • [1] OUTCOMES OF STEM CELL TRANSPLANTATION WITH FLUDARABINE AND MELPHALAN CONDITIONING FOR CHILDREN WITH ACQUIRED BONE MARROW FAILURE: A NATIONWIDE RETROSPECTIVE STUDY
    Yoshida, N.
    Yabe, H.
    Kudo, K.
    Kobayashi, R.
    Yabe, M.
    Inoue, M.
    Miki, M.
    Sakamaki, H.
    Kato, K.
    Kawa, K.
    Suzuki, R.
    Watanabe, K.
    Kojima, S.
    HAEMATOLOGICA, 2015, 100 : 4 - 4
  • [2] Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study
    Yoshida, Nao
    Yabe, Hiromasa
    Kudo, Kazuko
    Kobayashi, Ryoji
    Yabe, Miharu
    Inoue, Masami
    Miki, Mizuka
    Sakamaki, Hisashi
    Kato, Koji
    Kawa, Keisei
    Suzuki, Ritsuro
    Watanabe, Ken-ichiro
    Kojima, Seiji
    BLOOD, 2014, 124 (21)
  • [3] Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide
    Yoshida, Nao
    Takahashi, Yoshiyuki
    Yabe, Hiromasa
    Kobayashi, Ryoji
    Watanabe, Kenichiro
    Kudo, Kazuko
    Yabe, Miharu
    Miyamura, Takako
    Koh, Katsuyoshi
    Kawaguchi, Hiroshi
    Goto, Hiroaki
    Fujita, Naoto
    Okada, Keiko
    Okamoto, Yasuhiro
    Kato, Koji
    Inoue, Masami
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Kojima, Seiji
    Kato, Keisuke
    Muramatsu, Hideki
    Narita, Atsushi
    Wakamatsu, Manabu
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1272 - 1281
  • [4] Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide
    Nao Yoshida
    Yoshiyuki Takahashi
    Hiromasa Yabe
    Ryoji Kobayashi
    Kenichiro Watanabe
    Kazuko Kudo
    Miharu Yabe
    Takako Miyamura
    Katsuyoshi Koh
    Hiroshi Kawaguchi
    Hiroaki Goto
    Naoto Fujita
    Keiko Okada
    Yasuhiro Okamoto
    Koji Kato
    Masami Inoue
    Ritsuro Suzuki
    Yoshiko Atsuta
    Seiji Kojima
    Bone Marrow Transplantation, 2020, 55 : 1272 - 1281
  • [5] Conditioning Regimen for Allogeneic Bone Marrow Transplantation in Children With Acquired Bone Marrow Failure: Fludarabine/Melphalan vs. Fludarabine/Cyclophosphamide
    Yoshida, Nao
    Takahashi, Yoshiyuki
    Yabe, Hiromasa
    Kobayashi, Ryoji
    Watanabe, Kenichiro
    Kudo, Kazuko
    Yabe, Miharu
    Miyamura, Takako
    Koh, Katsuyoshi
    Kawaguchi, Hiroshi
    Goto, Hiroaki
    Fujita, Naoto
    Hara, Junichi
    Okamoto, Yasuhiro
    Kato, Koji
    Inoue, Masami
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Kojima, Seiji
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S95 - S95
  • [6] Efficacy and Safety of Hematopoietic Stem Cell Transplantation for Pediatric Bone Marrow Failure Syndromes Using a Reduced Intensity Conditioning Regimen with Fludarabine, Thiotepa, Melphalan, and ATG
    Schiff, Deborah
    Marion, Ayesha
    King, Catherine
    Gloude, Nicholas J.
    Leung, Wing H.
    Anderson, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S418 - S419
  • [7] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [8] Bone marrow transplantation for children with acquired bone marrow failure
    Hama, A.
    Manabe, A.
    Hasegawa, D.
    Nozawa, K.
    Suzuki, K.
    Narita, A.
    Muramatsu, H.
    Takahashi, Y.
    Watanabe, K.
    Ohara, A.
    Ito, M.
    Kojima, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S414 - S414
  • [9] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [10] A fludarabine-based conditioning for alternative donor haematopoietic stem cell transplantation in inherited bone marrow failure syndrome
    Yabe, M.
    Yabe, H.
    Shimizu, T.
    Morimoto, T.
    Koike, T.
    Takakura, H.
    Ohtsubo, K.
    Fukumura, A.
    Morimoto, T.
    Yoshida, H.
    Ohtsuka, Y.
    Shiomi, M.
    Kato, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S383 - S383